product image
A Need for Curative Treatment Expected to Attract the Pharma Players in the Hallux Valgus Market Landscape

Jan 15, 2021

Hallux Valgus, also know as Bunion, is the most common forefoot problem in adults. It is the most common pathologic entity of the big toe. It refers to the progressive swel...

Read More
product image
Gilead and Vir collaborate; Tessera scores $230M; Teladoc & Dexcom bring CGM Tech; Verve unveils lead candidate

Jan 14, 2021

Gilead and Vir Biotechnology Establish Clinical Collaboration  Gilead Sciences, Inc. and Vir Biotechnology, Inc. announced that the companies have entered into a clini...

Read More
product image
The Obesity Pandemic: What can we do about it?

Jan 13, 2021

Obesity today is a global crisis; the number of cases is on a continuous rise. As per the WHO,  “during the years 1975 to 2016, the prevalence of overweight or obese...

Read More
product image
Birinapant licensing; AvantGen, IGM pairs up for anti-SARS-CoV-2 antibodies; BeiGene, Novartis to co-dvelop Tislelizumab; Valo raises USD190 M; Bluebird Bio Spins-off

Jan 12, 2021

Medivir, IGM Biosciences enters into an exclusive licensing agreement for Birinapant Medivir AB has entered into an exclusive licensing agreement with IGM Biosciences to re...

Read More
product image
Parkinson’s Disease: How close are we to a cure?

Jan 11, 2021

Neurological disorders are the leading source of disability globally, and Parkinson’s is the fastest-growing neurological condition. It could be due to several factor...

Read More
product image
Increasing Prevalence and Upcoming Novel Therapeutic Approaches: What is Shaping the Hepatitis D Market Outlook?

Jan 8, 2021

Recent years have been experiencing a dramatic increase in the number of Hepatitis D cases. It is spreading at a rapid rate. DelveInsight estimated that the total diagnosed...

Read More
product image
Ikena bags $120M; Terns raises $87M for NASH; Ribometrix Genentech Collaboration; Hologic acquires Biotheranostics

Jan 7, 2021

Ikena secures USD 120 Million to advance a growing pipeline of cancer drugs Ikena Oncology has bagged USD 120 million to develop its expanding pipeline of cancer drugs. The...

Read More
product image
Medical Tourism: Road to Affordable and Quality Medical Care

Jan 6, 2021

In recent decades, apart from the movement of goods and services from one corner of the world to another, globalization has brought many new aspects in its folds. Medical t...

Read More
product image
Pfizer/ OPKO Health’s Somatrogon; FDA EU for SCONE device; Antengene ATG-010 for rrMM and rrDLBCL; SanBio STEMTRA Phase 2 Interim Results

Jan 5, 2021

Pfizer and OPKO Health: A step closer to FDA Nod for pediatric growth hormone deficiency (GHD) drug, Somatrogon Pfizer and Opko had joined hands in 2014 to develop somatrog...

Read More
product image
Search for the Cure Continues in the Chronic Hepatitis B Treatment Market

Jan 4, 2021

Hepatitis B virus (HBV) infection is the 10th leading cause of death worldwide. With 2 billion people infected all over, HBV infection is a reason behind 500 000 to 1.2 mil...

Read More
product image
Unmet Needs and Emerging Trends in the Acute Respiratory Distress Syndrome Market Landscape

Jan 1, 2021

Acute respiratory distress syndrome (ARDS) is a serious lung condition that is associated with a substantial rate of morbidity and mortality. It is a common cause of respir...

Read More
product image
Improving cancer immunotherapy; Senseonics’ Eversense delayed; FDA acknowledges Alkermes’ Resubmission; 3D breast ultrasound improves diagnosis

Dec 31, 2020

Improving cancer immunotherapy by recovering a warning system Cancer cells, most of the time, develop tactics to elude the immune system. A research team that is led by sci...

Read More
product image
Alcohol Use Disorder (AUD): When Drinking Becomes A Headache

Dec 30, 2020

Alcohol use is a serious health problem worldwide, leading to many physical, mental, and behavioral health problems. Besides physical health, it also leads to a significant...

Read More
product image
A USD 4.2 Billion Myovant/ Pfizer Deal; Audentes Therapeutics’ ASPIRO Trial Free to Proceed; First Generic of Drug for Severe Hypoglycemia Gets Approval; Teleflex Acquires Z-Medica

Dec 29, 2020

A USD 4.2 Billion Myovant/ Pfizer Deal Myovant Sciences have decided to put their forces and efforts together to advance the Prostate cancer market as they announced their ...

Read More
product image
Watch Out For Top Pipeline Therapies Making An Impact In The Bipolar Depression Market

Dec 28, 2020

Characterized by debilitating episodes of depression and mood elevation (mania or hypomania), Bipolar depression is an under-recognized and unappreciated phase of bipolar d...

Read More